These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 8661170

  • 1. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [Abstract] [Full Text] [Related]

  • 2. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ, Dahlberg PS, Ratz CA, Johnston JW, Gray BH, Haseman JR, Mayo KH, Dunn DL.
    Surgery; 1995 Aug; 118(2):318-24. PubMed ID: 7638748
    [Abstract] [Full Text] [Related]

  • 3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 4. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA, Wasiluk KR, Kellogg TA, Dunn DL.
    Surgery; 2000 Aug 15; 128(2):339-44. PubMed ID: 10923014
    [Abstract] [Full Text] [Related]

  • 5. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z, Hong Z, Guo W, Xiaoyun G, Gengfa L, Yongning L, Guangxia X.
    Int Immunopharmacol; 2004 Apr 15; 4(4):527-37. PubMed ID: 15099530
    [Abstract] [Full Text] [Related]

  • 6. Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria.
    Weiss J, Elsbach P, Shu C, Castillo J, Grinna L, Horwitz A, Theofan G.
    J Clin Invest; 1992 Sep 15; 90(3):1122-30. PubMed ID: 1522221
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A, Zarlenga DS, Bannerman DD.
    Am J Vet Res; 2007 Nov 15; 68(11):1151-9. PubMed ID: 17975968
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW.
    J Immunol; 1990 Jan 15; 144(2):662-6. PubMed ID: 2295804
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J.
    J Immunol; 1995 May 15; 154(10):5403-10. PubMed ID: 7730641
    [Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide neutralization by the antibacterial peptide CM4.
    Lin QP, Zhou LF, Li NN, Chen YQ, Li BC, Cai YF, Zhang SQ.
    Eur J Pharmacol; 2008 Oct 31; 596(1-3):160-5. PubMed ID: 18789317
    [Abstract] [Full Text] [Related]

  • 14. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H.
    Zhonghua Shao Shang Za Zhi; 2001 Apr 31; 17(2):102-4. PubMed ID: 11876922
    [Abstract] [Full Text] [Related]

  • 15. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A synthesized cationic tetradecapeptide from hornet venom kills bacteria and neutralizes lipopolysaccharide in vivo and in vitro.
    Yibin G, Jiang Z, Hong Z, Gengfa L, Liangxi W, Guo W, Yongling L.
    Biochem Pharmacol; 2005 Jul 15; 70(2):209-19. PubMed ID: 15935330
    [Abstract] [Full Text] [Related]

  • 20. Increased bactericidal/permeability increasing protein in patients with cirrhosis.
    Guerra-Ruiz A, Casafont F, Cobo M, Terán A, de-la-Peña J, Estebanez A, Pons-Romero F.
    Liver Int; 2010 Jan 15; 30(1):94-101. PubMed ID: 19765220
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.